Nebulizer Industry Outlook: Key Production analysis with Vendor

Posted by Nicky Arora on January 9th, 2020

The global Nebulizer Market size is expected to reach USD 1.4 billion by 2026, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.5% over the forecast period. Rising incidence rate of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population worldwide are the major factors leading to the market growth.

According to the Population Reference Bureau report, "Aging in the United States”, the geriatric population in U.S. is estimated to increase from 48 million in 2016 to 98 million by 2060. Elderly people are susceptible to respiratory diseases such as COPD and sleep apnea. Therefore, growing geriatric population is expected to expand the patient pool for manufacturers and propel the growth of the market.

On the other hand, drug loss during nebulization is the major factor restraining the market growth. However, this can also act as an opportunity for the mesh nebulizer manufacturers as the devices are manufactured to deliver accurate drug dosage while reduce drug loss. Furthermore, increasing commercial acceptance of mesh nebulizers due to accurate delivery of drug to the lung and lower residual volumes also aids in market growth.

Technological advancements such as drug-device combination is further expected to create newer opportunity in the nebulizer market. The key manufacturers are expected to dominate the market of drug device combinations till the generic mesh nebulizer manufacturers invest in the support infrastructure required for development of the new pharmaceuticals. For instance; In 2016, Sunovion filed the first application for the approval of SUN-101. A mesh nebulizer in combination with a drug for COPD (SUN-101) will be a significant step for boosting the adoption of nebulizers. Other companies such as Vectura also have products in late stage development, e.g., VR475, indicated for severe asthma, in Phase III trials.

To Request A Sample Copy @ https://www.grandviewresearch.com/industry-analysis/nebulizers-market/request/rs1

Further Key Findings from the Study Suggest:

  • Jet nebulizer held over 60.0% market share in 2018 owing to the greater penetration and low cost of the devices
  • Mesh nebulizers is the fastest growing segment with the CAGR of 7.7% due to various benefits including portability, convenience, homecare application and accurate dosage delivery
  • According to the Population Reference Bureau report, "Aging in the United States”, the geriatric population in U.S. is estimated to increase from 48 million in 2016 to 98 million by 2060.
  • The demand is expected to increase in homecare application. Easy availability of compact nebulizers that are ideal for home use and technological innovations in nebulizers to reduce the sound created by them and to improve their functionality are increasing their adoption in home healthcare.
  • North America dominated the regional nebulizer market segment in 2018. This high share can be attributed to increase in incidence of respiratory diseases, supportive government policies, favorable reimbursement schemes, rise in awareness, and increase use of home care products
  • As per the analysis of the U.S. and EU clinical trial databases, 2017, mesh nebulizers are more preferred for clinical trials sponsored by pharmaceutical companies over jet nebulizers.
  • Key players include Omron Corporation, Koninklijke Philips N.V., PARI Pharma, Allied Healthcare Products, Inc., Becton Dickinson and Company, Agilent Technologies, Medline Industries, Briggs Healthcare, Drive Medical and GF Health Products, Inc.

About Grand View Research:

Grand View Research is an India & U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 compnies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.

Contact:

Grand View Research, Inc.

201 Spear Street 1100,

San Francisco, CA 94105

United States

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Like it? Share it!


Nicky Arora

About the Author

Nicky Arora
Joined: October 15th, 2019
Articles Posted: 389

More by this author